Industry News
More patients with ovarian cancer are receiving chemotherapy before surgery
Jun 03, 2014
The use of chemotherapy before surgery to remove ovarian cancer has increased dramatically in recent decades, particularly among certain patients, according to a new analysis from Fox Chase Cancer... Read More
In patients with pancreatic or ovarian cancer, phase I study of DMOT4039A
Jun 03, 2014
A study presented at the 50th Annual Meeting of the American Society for Clinical Oncology (ASCO) describes the results of a phase I clinical trial of the investigational agent DMOT4039A against... Read More
For HIV+ patients diagnosed with lymphoma, hepatitis C reactivation does not worsen survival outcomes
Jun 03, 2014
More than a quarter of HIV+ patients are also infected with the Hepatitis C virus (HCV), which may complicate treatment and care decisions after a cancer diagnosis. Read More
The loss of a cell protein favors cancer cells while harming healthy cells
Jun 03, 2014
Janus kinases (JAKs) are proteins that can promote the growth of cancer cells. The protein JAK2 is of special therapeutic significance: its inactivation is believed to destroy cancer cells. Read More
Identification of mechanisms of ibrutinib resistance in chronic lymphocytic leukemia
Jun 03, 2014
A new study has discovered how resistance develops in patients taking ibrutinib, a new and highly effective drug for the treatment of chronic lymphocytic leukemia (CLL). Read More
Overall survival benefit shown for patients with stage III soft tissue sarcomas
Jun 03, 2014
Fox Chase Cancer Center researchers have carried out the first retrospective analysis of adjuvant chemotherapy's impact on overall survival in patients with stage III soft tissue sarcomas (STS)... Read More
Bladder cancer patients carrying three specific mutations benefit from early chemotherapy
Jun 03, 2014
Three genetic changes can predict whether a patient will benefit from chemotherapy before surgery to remove bladder cancer, according to new findings presented by Fox Chase Cancer Center researchers... Read More
For some, screening for colorectal cancer should continue well past age 75
Jun 02, 2014
Colorectal cancer (CRC) screening is cost-effective in elderly patients and should continue well past age 75 for those who have not already been screened, according to an article being published in... Read More
Smokers with BRCA2 gene mutation 'have increased lung cancer risk'
Jun 02, 2014
New research from The Institute of Cancer Research in the UK finds that smokers with a BRCA2 gene mutation have a 1 in 4 chance of developing lung cancer in their lifetime. Read More
Men with metastatic prostate cancer may live longer with chemo first
Jun 02, 2014
Giving chemo with hormone therapy instead of waiting for tumors to become resistant to hormone-blockers may prolong survival in metastatic hormone-sensitive prostate cancer. Read More
Previous Page Next Page